Literature DB >> 22966890

The current and future state of pharmacogenomics medical education in the USA.

Tracey J Nickola1, James S Green, Arthur F Harralson, Travis J O'Brien.   

Abstract

Healthcare professionals (e.g., physicians, physician assistants, pharmacists, nurses and genetic counselors) believe pharmacogenomics (PGx) is essential to personalized medicine; however, they still lack confidence prescribing, dosing, interacting with other healthcare professionals and counseling patients with regard to PGx. This is due to the inadequate incorporation of PGx content into professional curricula. Compared with other health professions, Doctor of Pharmacy programs have integrated more PGx content. Unlike other healthcare professionals, pharmacists have extensive training in pharmacology, drug selection, drug dosage, drug-drug interactions and are uniquely accessible to patients. We suggest pharmacists are the best poised to facilitate incorporating PGx into therapeutic decision-making. Based on our experience as undergraduate and pharmacy PGx educators, we further reflect on our experience educating future healthcare professionals on PGx.

Entities:  

Mesh:

Year:  2012        PMID: 22966890     DOI: 10.2217/pgs.12.113

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  21 in total

1.  Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation.

Authors:  Yee Ming Lee; Ryan P McKillip; Brittany A Borden; Catherine E Klammer; Mark J Ratain; Peter H O'Donnell
Journal:  Pharmacogenet Genomics       Date:  2017-05       Impact factor: 2.089

Review 2.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

Review 3.  First Responder to Genomic Information: A Guide for Primary Care Providers.

Authors:  Susanne B Haga
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

4.  Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.

Authors:  Susanne B Haga; Rachel Mills; Jivan Moaddeb; Nancy Allen LaPointe; Alex Cho; Geoffrey S Ginsburg
Journal:  Pharmacogenomics       Date:  2017-02-22       Impact factor: 2.533

Review 5.  Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.

Authors:  Kelly E Caudle; Nicholas J Keeling; Teri E Klein; Michelle Whirl-Carrillo; Victoria M Pratt; James M Hoffman
Journal:  Pharmacogenomics       Date:  2018-06-19       Impact factor: 2.533

Review 6.  Comparison of delivery strategies for pharmacogenetic testing services.

Authors:  Susanne B Haga; Jivan Moaddeb
Journal:  Pharmacogenet Genomics       Date:  2014-03       Impact factor: 2.089

7.  Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists.

Authors:  Rachel Mills; Susanne B Haga
Journal:  Pharmacogenomics       Date:  2013-06       Impact factor: 2.533

Review 8.  Educational strategies to enable expansion of pharmacogenomics-based care.

Authors:  Kristin Wiisanen Weitzel; Christina L Aquilante; Samuel Johnson; David F Kisor; Philip E Empey
Journal:  Am J Health Syst Pharm       Date:  2016-12-01       Impact factor: 2.637

9.  Integrating pharmacogenetic testing into primary care.

Authors:  Susanne B Haga
Journal:  Expert Rev Precis Med Drug Dev       Date:  2017-11-03

Review 10.  Primary-care providers' perceived barriers to integration of genetics services: a systematic review of the literature.

Authors:  Natalie A Mikat-Stevens; Ingrid A Larson; Beth A Tarini
Journal:  Genet Med       Date:  2014-09-11       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.